LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
US Stock MarketDetailed Quotes
FOLD Amicus Therapeutics
- 9.630
- -0.140-1.43%
Close Dec 27 16:00 ET
- 9.600
- -0.030-0.31%
Post 17:11 ET
2.88BMarket Cap-28.32P/E (TTM)
9.790High9.550Low1.65MVolume9.690Open9.770Pre Close15.90MTurnover0.67%Turnover RatioLossP/E (Static)298.81MShares14.53052wk High16.10P/B2.36BFloat Cap9.02052wk Low--Dividend TTM245.30MShs Float25.390Historical High--Div YieldTTM2.46%Amplitude1.765Historical Low9.630Avg Price1Lot Size
About Amicus Therapeutics Company
Amicus Therapeutics, Inc. operates as a biotechnology company. The firm focuses on discovering, developing and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio. The company was founded by John Francis Crowley on February 4, 2002 and is headquartered in Princeton, NJ.
Company Profile
SymbolFOLD
Company NameAmicus Therapeutics
Listing DateMay 31, 2007
Issue Price15.00
Founded2002
CEOMr. Bradley L. Campbell
MarketNASDAQ
Employees517
Fiscal Year Ends12-31
Address47 Hulfish Street
CityPrinceton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08542
Phone1-609-662-2000
Websitehttp://www.amicusrx.com
Company Executives
- Name
- Position
- Salary
- Bradley L. Campbell
- Director, President and Chief Executive Officer
- 8.20M
- Simon Nicolas Reade Harford
- Chief Financial Officer
- 2.98M
- Ellen S. Rosenberg
- Chief Legal Officer, General Counsel and Corporate Secretary
- 4.08M
- David M. Clark
- Chief People Officer
- 3.21M
- Samantha Prout
- Chief Accounting Officer and Controller
- --
- Jeffrey P. Castelli, PhD
- Chief Development Officer
- 3.67M
- Michael G. Raab
- Lead Independent Director and Chairman of the Board
- 426.25K
- Craig A. Wheeler
- Independent Director
- 398.50K
- Margaret G. McGlynn
- Independent Director
- 401.25K
- Glenn P. Sblendorio
- Independent Director
- 407.07K
- Lynn Dorsey Bleil
- Independent Director
- 397.50K
- Burke W. Whitman
- Independent Director
- 391.25K
- Michael A. Kelly
- Independent Director
- 391.25K
- Dr. Eiry W. Roberts, M.D.
- Independent Director
- 390.00K